| CIDARA THERAPEUTICS |
| USA |
| Gesundheit |
| US1717572069 / A3D4A6 |
| 20D0 (Frankfurt) / CDTX (NASDAQ) |
| FRA:20D0, ETR:20D0, 20D0:GR, NASDAQ:CDTX |
| - |
| https://www.cidara.com/ |
|
Cidara Therapeutics, Inc. is a clinical-stage biot..
>Volltext.. |
| 5954.81 Mio. EUR |
| 5593.12 Mio. EUR |
| - |
| -137.22 Mio. EUR |
| -158.69 Mio. EUR |
| -10.12 EUR |
| 1.7 Mio. EUR |
| 257.69 Mio. EUR |
| -114.19 Mio. EUR |
| 4.45 |
| -100% |
| -44.47% |
| - |
| - |
| - |
| - |
| CIDARA |
| 07.12.25 |